U.S. launch expected in early February – – Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduce the drive ...

Incyte (Nasdaq:INCY) and Syndax Pharmaceuticals (Nasdaq:SNDX) today announced that the U.S. Food and Drug Administration (FDA) has approved Niktimvo™ (axatilimab-csfr) in 9 mg and 22 mg vial sizes.

Healthcare professionals may recommend ginger for nausea relief, especially for motion sickness, during pregnancy, and when ...

Imagine feeling stuck—tired, weighed down, and far from the healthiest version of yourself. That’s exactly where I found myself a year ago, after a devastating car ...

a self-described member of the “liberal opposition” to Saudi Arabia who has voiced strong anti-Islamic and anti-immigration views. Two senior U.S. officials familiar with the matter identified ...

This training course will guide you through the principles of safe prescribing and demonstrate how to complete the National Standard Medication Charts correctly. The course comprises of 5 modules: ...

At the year-end meeting, North Korean officials committed to aggressively implementing strong anti-US measures to protect its security and national interests. https ...

Doctors assign it a grade from 1 to 4 to indicate how serious it is, and what treatments they need to use against it. Grade 1 is mild. Fever-reducers, antibiotics, anti-nausea drugs, and other ...

Stringent anti-pollution measure GRAP-4 has been revoked in Delhi and the neighbouring region amid a dip in pollution levels. The air quality index or AQI of Delhi has been "continuously improving ...